Yıldız Pehlivan, D., Yıldız, H. and Kaya, G. 2025. Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study. European Journal of Therapeutics. 31, 1 (Feb. 2025), 1–10. DOI:https://doi.org/10.58600/eurjther2520.